Stereotactic Body Radiation Therapy for Oligometastatic Renal Cell Carcinoma or Melanoma: Prognostic Factors and Outcomes

被引：5
|
作者：
Grossman, C. E. [1 ]
Okunieff, P. [2 ]
Brasacchio, R. A. [1 ]
Katz, A. W. [1 ]
Singh, D. P. [1 ]
Usuki, K. Y. [1 ]
Chen, Y. [1 ]
Milano, M. T. [3 ]
机构：
[1] Univ Rochester, Wilmot Canc Inst, Rochester, NY USA
[2] Univ Florida, Gainesville, FL USA
[3] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1061
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2508
引用
收藏
页码：E202 / E202
页数：1
相关论文
共 50 条
  • [1] Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma
    Franzese, Ciro
    Franceschini, Davide
    Di Brina, Lucia
    D'Agostino, Giuseppe Roberto
    Navarria, Pierina
    Comito, Tiziana
    Mancosu, Pietro
    Tomatis, Stefano
    Scorsetti, Marta
    JOURNAL OF UROLOGY, 2019, 201 (01): : 70 - 75
  • [2] Stereotactic body radiation therapy for oligometastatic renal cell carcinoma: improving outcomes in an otherwise radioresistant malignancy
    Beckham, Thomas H.
    Imber, Brandon S.
    Simone, Charles B., II
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [3] Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma EDITORIAL COMMENT
    Margulis, Vitaly
    JOURNAL OF UROLOGY, 2019, 201 (01): : 76 - 76
  • [4] Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma
    Jenny Que
    Hsing-Tao Kuo
    Li-Ching Lin
    Kuei-Li Lin
    Chia-Hui Lin
    Yu-Wei Lin
    Ching-Chieh Yang
    BMC Cancer, 16
  • [5] Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma
    Que, Jenny
    Kuo, Hsing-Tao
    Lin, Li-Ching
    Lin, Kuei-Li
    Lin, Chia-Hui
    Lin, Yu-Wei
    Yang, Ching-Chieh
    BMC CANCER, 2016, 16
  • [6] Stereotactic Body Radiation for Treatment of Oligometastatic Renal Cell Cancer
    Grespi, S.
    Menichelli, C.
    Fanelli, A.
    Ferrazza, P.
    Pastore, G.
    Frallicciardi, P. M.
    Casamassima, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E284 - E284
  • [7] Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma
    Ranck, Mark C.
    Golden, Daniel W.
    Corbin, Kimberly S.
    Hasselle, Michael D.
    Liauw, Stanley L.
    Stadler, Walter M.
    Hahn, Olwen M.
    Weichselbaum, Ralph R.
    Salama, Joseph Kamel
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (06): : 589 - 595
  • [8] Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Prognostic Factors Analysis
    Bibault, J.
    Lacornerie, T.
    Dewas, S.
    Fumagalli, I.
    Jerraya, H.
    Lartigau, E.
    Mirabel, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S329 - S330
  • [9] Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease
    Alongi, Filippo
    Arcangeli, Stefano
    Triggiani, Luca
    Mazzola, Rosario
    di Monale e Bastia, Michela Buglione
    Fersino, Sergio
    Baiguini, Anna
    Jereczek-Fossa, Barbara Alicja
    Magrini, Stefano Maria
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 117 : 48 - 56
  • [10] Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors
    Franceschini, Davide
    Teriaca, Maria Ausilia
    Di Cristina, Luciana
    Vernier, Veronica
    Faro, Lorenzo Lo
    Franzese, Ciro
    Comito, Tiziana
    Clerici, Elena
    Bellu, Luisa
    Dominici, Luca
    Spoto, Ruggero
    Massaro, Maria
    Navarria, Piera
    Scorsetti, Marta
    BRITISH JOURNAL OF RADIOLOGY, 2023, 96 (1144):
12345